Healthstream (HSTM) Current Deferred Revenue (2010 - 2026)

Healthstream (HSTM) has 17 years of Current Deferred Revenue data on file, last reported at $106.4 million in Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $106.4 million, up 4.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $106.4 million (up 4.31% YoY), and the FY2025 annual result was $88.4 million, up 4.97% from the prior year.
• Current Deferred Revenue rose to $106.4 million in Q1 2026 per HSTM's latest filing, from $88.4 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $106.4 million in Q1 2026 and troughed at $77.6 million in Q3 2022.
• A 5-year average of $87.9 million and a median of $85.7 million in 2025 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2022 and 2024: Current Deferred Revenue climbed 7.66% in 2022, then fell 0.34% in 2024.
• A 5-year view of Current Deferred Revenue shows it stood at $79.5 million in 2022, then grew by 5.23% to $83.6 million in 2023, then increased by 0.72% to $84.2 million in 2024, then advanced by 4.97% to $88.4 million in 2025, then climbed by 20.34% to $106.4 million in 2026.
• Business Quant data shows HSTM's Current Deferred Revenue at $106.4 million in Q1 2026, $88.4 million in Q4 2025, and $85.7 million in Q3 2025.